These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7820228)

  • 1. Monoclonal antibodies to high-incidence Kell epitopes: characterization and application in automated screening of donor samples.
    Inglis G; Fraser RH; McTaggart S; Sheridan R; Forrest AH; Mitchell R
    Transfus Med; 1994 Sep; 4(3):209-12. PubMed ID: 7820228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K12 is located on the Kell blood group protein in proximity to K/k and Jsa/Jsb.
    Reid ME; Oyen R; Redman CM; Gillespie G; Jones J; Eckrich R
    Vox Sang; 1995; 68(1):40-5. PubMed ID: 7725670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of anti-kell monoclonal antibodies using transfected cells as the immunogen.
    Chu TH; Yazdanbakhsh K; Oyen R; Smart E; Reid ME
    Br J Haematol; 1999 Sep; 106(3):817-23. PubMed ID: 10468879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens.
    Jones J; Reid ME; Oyen R; Harris T; Moscarelli S; Co S; Leger R; Beal C; Cardillo K
    Vox Sang; 1995; 69(1):53-60. PubMed ID: 7483493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry and quantification of antigen sites.
    Parsons SF; Gardner B; Anstee DJ
    Transfus Med; 1993 Jun; 3(2):137-42. PubMed ID: 7690639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new monoclonal anti-k (anti-KEL2) reagent.
    Strobel E
    Clin Lab; 2010; 56(9-10):385-9. PubMed ID: 21086783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human and chimpanzee Kell blood group systems.
    Redman CM; Lee S; ten Huinink D; Rabin BI; Johnson CL; Oyen R; Marsh WL
    Transfusion; 1989; 29(6):486-90. PubMed ID: 2749871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of IgM monoclonal reagents licensed for tube tests in column agglutination technology.
    Morelati F; Burlini A; Reis KJ; Drago F; Revelli N; Villa MA; Guffanti A; Italiano Z; Parravicini A; Rebulla P; Sirchia G
    Transfusion; 1998; 38(11-12):1037-40. PubMed ID: 9838934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdonor incompatibility due to anti-Kell antibody undetectable by automated antibody screening.
    West NC; Jenkins JA; Johnston BR; Modi N
    Vox Sang; 1986; 50(3):174-6. PubMed ID: 3716289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells.
    Branch DR; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1985 Mar; 59(3):505-12. PubMed ID: 2578808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human monoclonal antibody to high-frequency red cell antigen Jra.
    Miyazaki T; Kwon KW; Yamamoto K; Tone Y; Ihara H; Kato T; Ikeda H; Sekiguchi S
    Vox Sang; 1994; 66(1):51-4. PubMed ID: 8146983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible suppression of fetal erythropoiesis by the Kell blood group antibody anti-Kp(a).
    Tuson M; Hue-Roye K; Koval K; Imlay S; Desai R; Garg G; Kazem E; Stockman D; Hamilton J; Reid ME
    Immunohematology; 2011; 27(2):58-60. PubMed ID: 22356520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).
    Jongerius JM; Daniels GL; Overbeeke MA; Petty AC; Reid M; Oyen R; Rijksen H; van Leeuwen EF
    Vox Sang; 1996; 71(1):43-7. PubMed ID: 8837356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies with specificities related to the Kell blood group system.
    Parsons SF; Judson PA; Spring FA; Mallinson G; Anstee DJ
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):401-5. PubMed ID: 3212321
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological properties of 18 anti-B and 12 anti-A,B monoclonal antibodies.
    Rouger P; Liberge G; Oriol R; Gane P; Salmon C
    Rev Fr Transfus Immunohematol; 1987 Dec; 30(5):569-77. PubMed ID: 3452897
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal anti-K14 and anti-K2.
    Nichols ME; Rosenfield RE; Rubinstein P
    Vox Sang; 1987; 52(3):231-5. PubMed ID: 3300028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhesus and Kell Phenotyping of Voluntary Blood Donors: Foundation of a Donor Data Bank.
    Karim F; Moiz B; Muhammad FJ; Ausat F; Khurshid M
    J Coll Physicians Surg Pak; 2015 Oct; 25(10):757760-760. PubMed ID: 26454398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunohematologic routine methods using the new erythrocyte-magnetized technology on the QWALYS 2 system.
    Schoenfeld H; Bulling K; von Heymann C; Neuner B; Kalus U; Kiesewetter H; Pruss A
    Transfusion; 2009 Jul; 49(7):1347-52. PubMed ID: 19389030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.